Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Stock Quote Today & Recent News BIOAGE Labs Inc BIOA

BioAge Labs, Inc. is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. Its lead product is BGE-102, a structurally novel, orally available small molecule NLRP3 inhibitor with high potency and brain penetration. In preclinical obesity models, BGE-102 resulted in weight loss as... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >

Current News (NDAQ:BIOA)

BioAge Labs Reports First Quarter 2025 Financial Results and Provides Business Updates

GlobeNewswire 13 days ago

Lifshitz Law PLLC Announces Investigations of Sun Communities, Inc. (NYSE: SUI), MGP Ingredients, Inc. (NASDAQ: MGPI), Nextracker Inc. (NASDAQ: NXT), and BioAge Labs, Inc. (NASDAQ: BIOA)

ACCESS Newswire April 28, 2025

BioAge Labs Reports Full Year 2024 Financial Results and Provides Business Updates from the Fourth Quarter of 2024

GlobeNewswire March 20, 2025

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of March 10, 2025 in BioAge Labs, Inc. Lawsuit - BIOA

ACCESS Newswire March 10, 2025

Final Deadline for the BioAge Labs, Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - BIOA

PR Newswire March 10, 2025

Levi & Korsinsky Notifies BioAge Labs, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - BIOA

ACCESS Newswire March 10, 2025

BIOA Deadline Today: BIOA Investors Have Opportunity to Lead BioAge Labs, Inc. Securities Lawsuit

PR Newswire March 10, 2025

Shareholders that Lost Money on BioAge Labs, Inc. (BIOA) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More

ACCESS Newswire March 10, 2025

BIOA Investors Have Opportunity to Lead BioAge Labs, Inc. Securities Fraud Lawsuit with the Schall Law Firm

Business Wire March 10, 2025

Opinion & Analysis (NDAQ:BIOA)

No current opinion is available.

Bullboard Posts (NDAQ:BIOA)